+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The effect of subcutaneously administered biosynthetic human proinsulin on glucose kinetics in normal men a comparison with human nph insulin



The effect of subcutaneously administered biosynthetic human proinsulin on glucose kinetics in normal men a comparison with human nph insulin



Diabetologia 32(7): 524A




(PDF emailed within 1 workday: $29.90)

Accession: 033784381

Download citation: RISBibTeXText


Related references

The biological activity of subcutaneously injected biosynthetic human proinsulin and human insulin zinc suspension. Diabetologia 27(2): 250A, 1984

Biosynthetic human proinsulin, a new therapeutic compound for diabetics? A comparative study of biosynthetic human proinsulin with biosynthetic human insulin. Hormone and Metabolic Research. Supplement Series 18: 16-21, 1988

Hypoglycemic effect of subcutaneously injected biosynthetic human proinsulin in healthy man. Hormone and Metabolic Research. Supplement Series 18: 22-24, 1988

Comparisons of insulin and biosynthetic human proinsulin actions in cultured hepatocytes. Kinetics and biologic potencies. Hormone and Metabolic Research 22(5): 283-288, 1990

Biosynthetic human insulin and proinsulin have additive but not synergistic effects on total body glucose disposal. Journal of Clinical Endocrinology and Metabolism 58(6): 1094-1098, 1984

Comparison of variability potency and kinetics of subcutaneous human proinsulin and human nph insulin. Diabetologia 30(7): 538A-539A, 1987

Binding of biosynthetic human insulin to erythrocytes of normal and insulin-dependent diabetic subjects: comparison with pork and human pancreatic insulin. Diabetes Care 4(2): 215-219, 1981

Pharmacokinetics of subcutaneously administered human, porcine and bovine neutral soluble insulin to normal man. Hormone and Metabolic Research 16 Suppl 1: 195-199, 1984

Treatment of type ii diabetic patients with biosynthetic human proinsulin evaluation of glucose control peripheral and hepatic insulin resistance. Diabetes Research & Clinical Practice 5(SUPPL 1): S476, 1988

In vitro activity of biosynthetic human proinsulin. Receptor binding and biologic potency of proinsulin and insulin in isolated rat adipocytes. Diabetes 33(11): 1062-1067, 1984

Biosynthetic human insulin: effect in healthy men on plasma glucose and non-esterified fatty acids in comparison with highly purified pork insulin. Diabetes Care 4(2): 175-179, 1981

Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments. Hormone and Metabolic Research. Supplement Series 18: 60-67, 1988

The effect of biosynthetic human proinsulin on the hepatic response to glucagon in insulin-deficient diabetes. Journal of Clinical Endocrinology and Metabolism 64(3): 476-481, 1987

(A-C-B) human proinsulin, a novel insulin agonist and intermediate in the synthesis of biosynthetic human insulin. Journal of Biological Chemistry 267(1): 419-425, 1992

Human proinsulin bioactivity and pharmacokinetics after intravenous and subcutaneous injection of human proinsulin in comparison to insulin. Diabetes Research & Clinical Practice (SUPPL 1): S496, 1985